ESTIMATED
05/01/2024
05/01/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 4 | $0.52 | $0.52 | $0.52 |
Q2 2024 | 11 | $0.32 | $0.55 | $0.45 |
Q3 2024 | 5 | $0.54 | $0.54 | $0.54 |
Q4 2024 | 8 | $0.57 | $0.57 | $0.57 |
Q1 2025 | 5 | $0.87 | $0.87 | $0.87 |
Q2 2025 | 5 | $0.61 | $0.61 | $0.61 |
Q3 2025 | 7 | $0.59 | $0.59 | $0.59 |
Q4 2025 | 10 | $0.73 | $0.73 | $0.73 |
Pfizer Inc. last posted its earnings results on Wednesday, May 1st, 2024. The company reported $0.82 earnings per share for the quarter, topping analysts' consensus estimates of $0.516 by $0.304. The company had revenue of 14.88 B for the quarter and had revenue of 58.50 B for the year. Pfizer Inc. has generated $0 earnings per share over the last year ($0.38 diluted earnings per share) and currently has a price-to-earnings ratio of -537.03. Pfizer Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 30th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/08/2024 | Q1 2024 | $0.55 | $13.87 B | $14.88 B | 02/22/2024 | Q4 2023 | -$0.59 | $14.37 B | $14.25 B | 11/08/2023 | Q3 2023 | -$0.42 | $13.34 B | $13.23 B | 08/09/2023 | Q2 2023 | $0.41 | $12.73 B | 05/10/2023 | Q1 2023 | $0.98 | $18.28 B | 02/23/2023 | Q4 2022 | $0.89 | $24.38 B | $24.29 B | 11/09/2022 | Q3 2022 | $1.54 | $22.64 B | 08/10/2022 | Q2 2022 | $1.77 | $27.74 B | 05/11/2022 | Q1 2022 | $1.40 | $25.66 B | 02/24/2022 | Q4 2021 | $0.60 | $24.16 B | $23.84 B | 11/12/2021 | Q3 2021 | $1.45 | $24.09 B | 08/12/2021 | Q2 2021 | $0.99 | $18.98 B | 05/13/2021 | Q1 2021 | $0.87 | $14.58 B | 02/25/2021 | Q4 2020 | $0.11 | $11.67 B | $11.68 B | 11/05/2020 | Q3 2020 | $0.39 | $12.13 B | 08/06/2020 | Q2 2020 | $0.63 | $11.80 B | 05/07/2020 | Q1 2020 | $0.60 | $12.03 B | 02/27/2020 | Q4 2019 | -$0.06 | $12.61 B | $12.69 B | 11/07/2019 | Q3 2019 | $1.38 | $12.68 B | 08/08/2019 | Q2 2019 | $0.91 | $13.40 B | $13.26 B |
---|
A. Pfizer Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 30th, 2024 based off last year's report dates.
A. In the previous quarter, Pfizer Inc. (NYSE:PFE) reported $0.82 earnings per share (EPS) to beat the analysts' consensus estimate of $0.516 by $0.304.
A. The conference call for Pfizer Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Pfizer Inc.'s latest earnings report can be read online.
A. Pfizer Inc. (NYSE:PFE) has a recorded annual revenue of $58.50 B.
A. Pfizer Inc. (NYSE:PFE) has a recorded net income of $58.50 B. Pfizer Inc. has generated $0.38 earnings per share over the last four quarters.
A. Pfizer Inc. (NYSE:PFE) has a price-to-earnings ratio of -537.03 and price/earnings-to-growth ratio is -37.9.